Page last updated: 2024-09-03

icrf 193 and Lung Neoplasms

icrf 193 has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ebi, H; Hayashita, Y; Maeno, K; Masuda, A; Nakagawa, T; Osada, H; Shimokata, K; Sugito, N; Takahashi, T; Yanagisawa, K	1

Other Studies

1 other study(ies) available for icrf 193 and Lung Neoplasms

Article	Year
Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines. Cancer research, 2004, Jul-15, Volume: 64, Issue:14 Topics: Antineoplastic Agents; Cell Line, Tumor; Diketopiperazines; DNA Damage; DNA Helicases; DNA Topoisomerases, Type II; DNA, Neoplasm; Exodeoxyribonucleases; G2 Phase; Humans; Lung Neoplasms; Piperazines; RecQ Helicases; Topoisomerase II Inhibitors; Werner Syndrome Helicase	2004

Article

Year

Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines.

Cancer research, 2004, Jul-15, Volume: 64, Issue:14

Topics: Antineoplastic Agents; Cell Line, Tumor; Diketopiperazines; DNA Damage; DNA Helicases; DNA Topoisomerases, Type II; DNA, Neoplasm; Exodeoxyribonucleases; G2 Phase; Humans; Lung Neoplasms; Piperazines; RecQ Helicases; Topoisomerase II Inhibitors; Werner Syndrome Helicase

2004